Postantifungal effect and effects of sub-MIC concentrations on previously treated Candida sp influence of growth phase

被引:8
作者
García, MT [1 ]
Llorente, MT [1 ]
Mínguez, F [1 ]
Prieto, J [1 ]
机构
[1] Univ Complutense Madrid, Sch Med, Dept Microbiol, E-28040 Madrid, Spain
关键词
D O I
10.1053/jinf.2002.1042
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study evaluates the influence of growth phase on the postantifungal effect (PAFE) and on the effect of sub-MIC concentrations (1 /4 x MIC) on Candida sp. in PAFE stage (PAFSE). Methods: This stage was induced by pre-treatments of 1.5 h of C. albicans or C. glabrata in their exponential or stationary phase, with I x, 4 x or 8 x MIC of four antifungal agents that are fundamental for modern candidiasis therapy. Results: Ketoconazole and fluconazole induced longer PAFSEs on microorganisms in logarithmic growth phase. However, this influence did not exist in the case of PAFSEs induced by AmB and 5-Fe or with the postantifungal effect induced by the four antifungal agents. In any way, significant PAFEs were always observed for Amphotericin B and 5-fluorocytosine (0.8-4.8 and 0.5-3 h, respectively, depending on the treatment dose). These values were increased (2.3-3.6 and 1.4-3.2 h respectively, depending on the pre-treatment dose) by posterior exposition to 1/4 x MIC of the respective antifungal agent. in the case of ketoconazole and fluconazole, both antimycotics were not able to induce significant PAFEs, but posterior treatments to 1/4 x MIC of each of the two azoles led in both yeast species to significant PAFSE of up to 2.6 h duration with ketoconazole, and 0.8 h with fluconazole, depending on the pre-treatment concentration. Conclusion: The growth phase of microorganisms should be considered in the planning of dosage protocols with azoles, because if the concentration applied is not high enough, the sub-MIC effects could be no significant for fungi in stationary phase of large wounds. Amphotericin B and 5-fluorocytosine induced significant postantifungal effect on Candida sp. This effect was increased by posterior exposition to sub-MIC concentration of the antifungal agents. Ketoconazole and fuconazole were not able to induce significant PAFEs at the concentrations tested, but posterior treatments to sub-MIC concentrations led to significant PATSE. The growth phase of the culture at the time of its pre-treatment did not influence the length of the PAFE induced in it. However, the effect of the sub-MIC concentrations of Kz or Flu in yeast in PAFE phase was greater on yeast in exponential phase than for cultures in stationary phase. (C) 2002 The British Infection Society. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:263 / 267
页数:5
相关论文
共 19 条
[2]   RATES OF GERM TUBE FORMATION FROM GROWING AND NONGROWING YEAST-CELLS OF CANDIDA-ALBICANS [J].
BUCHAN, ADB ;
GOW, NAR .
FEMS MICROBIOLOGY LETTERS, 1991, 81 (01) :15-18
[3]  
COPE JE, 1980, SABOURAUDIA, V18, P211
[4]  
Craig W.A., 1991, Antibiotics in Laboratory Medicine, V3rd ed., P403
[5]  
García MT, 1999, SCAND J INFECT DIS, V31, P501, DOI 10.1080/00365549950164049
[6]   POSTANTIBIOTIC EFFECTS AND POSTANTIBIOTIC SUB-MIC EFFECTS OF BENZYLPENICILLIN ON VIRIDANS STREPTOCOCCI ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS [J].
KIKUCHI, K ;
ENARI, T ;
MINAMI, S ;
HARUKI, K ;
SHIBATA, Y ;
HASEGAWA, H ;
KATAHIRA, J ;
TOTSUKA, K ;
SHIMIZU, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) :687-696
[7]   ADHERENCE OF CANDIDA-ALBICANS AND OTHER CANDIDA SPECIES TO MUCOSAL EPITHELIAL-CELLS [J].
KING, RD ;
LEE, JC ;
MORRIS, AL .
INFECTION AND IMMUNITY, 1980, 27 (02) :667-674
[8]   CHARACTERIZATION OF CANDIDA-ALBICANS ADHERENCE TO HUMAN VAGINAL EPITHELIAL-CELLS INVITRO [J].
LEE, JC ;
KING, RD .
INFECTION AND IMMUNITY, 1983, 41 (03) :1024-1030
[9]   INVITRO ACTIVITY OF SCH39304 IN COMPARISON WITH AMPHOTERICIN-B AND FLUCONAZOLE [J].
MEUNIER, F ;
LAMBERT, C ;
VANDERAUWERA, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (02) :227-236
[10]   Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans [J].
Minguez, F ;
Lima, JE ;
Garcia, MT ;
Prieto, J .
CHEMOTHERAPY, 1996, 42 (04) :273-279